Related Experiment Video
Updated: Dec 17, 2025
11:08
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
30.8K
Liver disease in pregnancy
Yukifumi Sasamori1, Atsushi Tanaka2, Takuya Ayabe1
1Department of Obstetrics and Gynecology.
Summary
Liver diseases in pregnancy, whether unique to gestation or pre-existing, require prompt diagnosis and management. A collaborative approach is crucial for improving maternal and fetal outcomes in these complex cases.
Area of Science:
- Hepatology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Liver diseases during pregnancy are a significant concern, arising from pregnancy-specific conditions or pre-existing/coincidental liver disorders.
- Conditions unique to pregnancy include hyperemesis gravidarum, hypertensive disorders (pre-eclampsia/eclampsia), HELLP syndrome, intrahepatic cholestasis, and acute fatty liver of pregnancy.
- Chronic liver diseases like autoimmune liver diseases and non-alcoholic fatty liver disease can also affect or be affected by pregnancy.
Purpose of the Study:
- To provide an up-to-date review of liver diseases in pregnancy.
- To discuss epidemiology, etiology, clinical features, and outcomes.
- To promote physician understanding and improve patient outcomes.
Main Methods:
- This is a review article.
- Synthesizes current knowledge on liver diseases in pregnancy.
- Focuses on epidemiology, etiology, clinical presentation, and outcomes.
Main Results:
- Liver diseases in pregnancy can lead to adverse maternal and fetal outcomes.
- Prompt diagnosis and management are critical.
- A multidisciplinary approach involving hepatologists and obstetricians is essential.
Conclusions:
- Effective management of pregnancy-related liver diseases necessitates collaboration between specialists.
- Improved understanding of these conditions can lead to better patient care.
- Addressing liver diseases in pregnancy is vital for optimizing maternal and fetal health.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
1.7K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
115
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
115
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
145
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
145
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
744
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
744
01:30Liver Physiology
3.3K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.3K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
116
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
116